The covid-19 vaccine being developed by Johnson & Johnson has been submitted for approval to the European Medicines Agency.
The EMA says it could make a decision on the single-shot vaccine by the middle of next month.
EMA has received an application for conditional marketing authorisation for #COVID19 Vaccine Janssen:
👉https://t.co/vBZXDaINdN pic.twitter.com/PBFxayMMkL— EU Medicines Agency (@EMA_News) February 16, 2021
However, this is assuming the data relating to the vaccine’s efficacy, safety and quality are sufficiently comprehensive and robust.
The Janssen jab has been shown to be 66 per cent effective against covid-19.
Ireland is in line to receive 2.2 million doses of the J&J vaccine over the coming months.
